Teva to close Puerto Rico plant, cut 200 jobs as part of restructuring plan

Teva Pharmaceuticals will close its manufacturing plant in Manati, Puerto Rico, which will eliminate approximately 200 jobs, according to a STAT Pharmalittle newsletter.

Advertisement

The move is part of Teva’s broad restructuring plan, which calls for cutting 14,000 jobs worldwide and consolidating six of its seven U.S. sites into one location. The drugmaker announced restructuring plans to offset approximately $35 billion of debt.

A spokesperson confirmed to STAT that Hurricane Maria, which devistated the island in September, was not a factor in the decision.

More articles on supply chain:
Google venture arm invests in company developing universal flu vaccine
Congress passes 2-year delay of medical device tax: 4 things to know
Drug price controversy revived: PTC Therapeutics raises muscular dystrophy treatment price by 9%

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.